| EGFR 突变种类与临床疗效关联 |
| |
| 引用本文： | 陈亚楠 张菊 刘文超. EGFR 突变种类与临床疗效关联[J]. 现代生物医学进展, 2011, 11(5): 943-945 |
| |
| 作者姓名： | 陈亚楠 张菊 刘文超 |
| |
| 作者单位： | 1. 第四军医大学西京医院肿瘤科,陕西,西安,710032
2. 第四军医大学药学系基因所,陕西,西安,710032 |
| |
| 摘 要： | 癌组织中表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变是应用靶向药物EGFR酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)治疗的一个重要相关因素及预测指标。对其突变的检测可以指导TKI类药物(TKIs)的最佳应用。该种突变常出现在非小细胞肺癌(NSCLC)中,尤其是在亚洲女性、肺腺癌、非吸烟者中,与非小细胞肺癌患者对TKIs治疗的敏感性密切相关。本文旨在探讨利用EGFR基因的已知突变热点的相关知识选择适合不同分子遗传学背景的群体或/和个体的"个体化"治疗方案,最终达到延长肺癌患者生存时间和提高生活质量的双重目的。
|
| 关 键 词： | 表皮生长因子受体(EGFR) 突变 非小细胞肺癌(NSCLC) 分子靶向治疗 |
Relationship between Mutations of the Epidermal Growth Factor ReceptorGene and Clinical Evaluation |
| |
| CHEN Ya-nan,ZHANG Ju,LIU Wen-chao. Relationship between Mutations of the Epidermal Growth Factor ReceptorGene and Clinical Evaluation[J]. Progress in Modern Biomedicine, 2011, 11(5): 943-945 |
| |
| Authors: | CHEN Ya-nan ZHANG Ju LIU Wen-chao |
| |
| Affiliation: | 1(1 Department of Oncology,Xijing Hospital,The Fourth Military Medical University;Xi’an,710032,China;2 Institute of Gene Diagnosis,State Key Laboratory of Cancer Biology,School of Pharmacy,The Fourth Military Medical University,Xi’an,710032,China) |
| |
| Abstract: | Mutations in the epidermal growth factor receptor (EGFR) gene have been reported to be present in cancer organizesand related to the responsiveness of tumors to EGFR tyrosine kinase inhibitors, which suggest its usefulness as a biomarker. Morever,EGFR gene mutation was frequently tested in NSCLC, especially in Asians, females, nonsmokers, and adenocarcinomas. EGFR genemutation was related to gefitinib therapy sensibility. This article was to discuss "individuation". Extension patient''s life and enhancementquality of life could be achieved finally. |
| |
| Keywords: | |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《现代生物医学进展》浏览原始摘要信息 |
|
点击此处可从《现代生物医学进展》下载免费的PDF全文 |
|
